반응식
[NH2:1][C@@H:2]([C:5]([OH:7])=[O:6])[CH2:3]O.N[C@@H]([C:17]([OH:19])=O)CCCNC(=N)N.[NH2:20][C@@H](C(O)=O)CCSC.N[C@@H](C(O)=O)CCCCN.N[C@@H](C(O)=O)CC1C=CC=CC=1.N[C@@H](C(O)=O)CC(C)C.N[C@@H](C(O)=O)[C@@H](CC)C.N[C@@H](C(O)=O)CC1C2C(=CC=CC=2)NC=1.C(SSC[C@@H](N)C(O)=O)[C@@H](N)C(O)=O>>[NH2:1][C@H:2]([C:5]([OH:7])=[O:6])[CH2:3][C:17](=[O:19])[NH2:20]참가 물질
10
실험 절차
According to a particularly advantageous further development of the invention the D-serine represented by X is replaced by D-arginine, D-methionine, D-lysine or D-phenylalanine, D-leucine, D-isoleucine, D-tryptophane or D-cystine.
출처 및 근거
- ORD 기록
- ord-a960b21c34a044a98fe5d817e6cb1437
- 출처 데이터셋
- uspto-grants-1985_11
- 특허 번호
- US04555403
연결된 노트
불러오는 중…